Log In
BCIQ
Print this Print this
 

SEL201

  Manage Alerts
Collapse Summary General Information
Company Selvita S.A.
DescriptionSmall molecule MAP kinase interacting serine-threonine kinase 1 (MKNK1; MNK1) and MNK2 inhibitor
Molecular Target MAP kinase interacting serine-threonine kinase 1 (MKNK1) (MNK1) ; MAP kinase interacting serine-threonine kinase 2 (MKNK2) (MNK2)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today